Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Taiwan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20132
20141
20151
20191
20211
20222
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Chang Gung Memorial Hospital2
AstraZeneca1
Cathay General Hospital1
Daiichi Sankyo1
DualityBio Inc.1
Exelixis1
GlaxoSmithKline1
Hoffmann-La Roche1
Mackay Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms15
Endometrial Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Melanoma4
Pancreatic Neoplasms4
Stomach Neoplasms4
Uterine Cervical Neoplasms4
Breast Neoplasms3
Carcinoma, Hepatocellular3
Colorectal Neoplasms3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.